Sequential versus concurrent chemotherapy for adjuvant breast cancer: does dose intensity matter? [electronic resource]
- British journal of cancer 07 2017
- 157-300 p. digital
Publication Type: Editorial; Comment
1532-1827
10.1038/bjc.2017.176 doi
Breast Breast Neoplasms Chemotherapy, Adjuvant Docetaxel Epirubicin Humans